Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis. [electronic resource]
Producer: 20060713Description: 48 p. digitalISSN:- 1488-2329
- Bone Density Conservation Agents -- adverse effects
- Canada
- Diphosphonates -- adverse effects
- Drug Interactions
- Female
- Fractures, Bone -- etiology
- Humans
- Osteoporosis -- drug therapy
- Parathyroid Hormone -- adverse effects
- Practice Guidelines as Topic
- Review Literature as Topic
- Teriparatide -- adverse effects
No physical items for this record
Publication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.